Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 303

TTU’s Innovation Hub spawns 12 businesses

TTU Innovation Hub graduated six companies from its accelerator and helped its wider affiliate community secure a total of $3.5m in grant funding.

Feb 20, 2019

Phylagen traces corporates for $14m series A

The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.

Feb 20, 2019

Laurentian hires Haché

Robert Haché will end his tenure as vice-president of research and innovation at York University to lead Laurentian University from July.

Feb 20, 2019

Jandhyala bids CoMotion farewell

Vikram Jandhyala is standing down as executive director of University of Washington’s CoMotion but will remain with the university in other capacities.

Feb 19, 2019

Liverpool universities grasp Sciontec

University of Liverpool, Liverpool John Moores and Liverpool City Council will launch the Sciontec Liverpool fund to drive works for the city’s $2.6bn Knowledge Quarter Liverpool project.

Feb 19, 2019

Glycotest captures $3m from Fosun Pharma

The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.

Feb 19, 2019

Maryland mulls $16m Tedco program

State lawmakers are considering plans to fund supports for Maryland’s cybersecurity and life sciences sectors administered by local economic development agency Tedco.

Feb 19, 2019

Passage Bio follows $116m series A trajectory

Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.

Feb 19, 2019

NetScientific to delist from Aim

Commercialisation firm NetScientific will delist from Aim to free up cash for its portfolio companies, having failed to attract concrete offers after putting itself up for an acquisition.

Feb 19, 2019

Vor roars to $42m series A

Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.

Feb 18, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here